Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT03041792 | Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects | PHASE1 | COMPLETED | 61 | — | — | Feb 20, 2017 | Jan 16, 2018 | Jul 26, 2019 | 1 | United States |
The mean energy intake was collected to assess the effect of liraglutide on food intake in non-diabetic, obese participants. Observed food intake was measured as the total number of calories consumed during the specified time period, calculated as the difference of the total number of calories provided minus the total number of calories remaining after meals. Mean energy intakes at Visit 4 was defined as the mean values of the measurements at Study Day 20 and 21. Same definition applies to Visit 5 (Study Day 41 and 42). Baseline was defined as the mean of Visit 3 (Study Day -1 and 0).
| Arm | Type | Description |
|---|---|---|
| Active | EXPERIMENTAL | Liraglutide |
| Placebo | PLACEBO_COMPARATOR | Placebo comparator |
| Name | Type | Description |
|---|---|---|
| Liraglutide | DRUG | Liraglutide |
| Placebo | OTHER | Placebo |
Inclusion Criteria: * Males and female subjects; * Body Mass Index 30-40 kg/m2; Exclusion Criteria: * Evidence of history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug a...